Results 121 to 130 of about 1,960 (195)

Miltefosine implementation for treatment of cutaneous leishmaniasis: access indicators in the state of Minas Gerais, 2021-2024. [PDF]

Epidemiol Serv Saude
Silva SN, Saliba MF, Ribeiro LR, Cota G.
europepmc   +1 more source

Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Caffaratti M, Cañás M, Domosbian DE, Giraudo E, González AM, Lorenzo A, Núñez Montoya S, Rocha MT, Traverso ML, Uema S.   +9 more
europepmc   +1 more source

[Patterns of psychotropic medication dispensing in rural primary care in northern Chile]. [PDF]

Aten Primaria
García-González W, Venegas-Bustos J, Briceño-Moya J, Roco-Videla A, Flores-Carrasco S.   +4 more
europepmc   +1 more source

Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]

Biomedica
Panesso GA, Martínez JD, Velasco A, Forero S, Perdomo D, Villamil Á, González ER, Jiménez CA.   +7 more
europepmc   +1 more source

[Pharmaceutical services in expanded access, compassionate use, and post-trial access: the perspective of clinical researchers]. [PDF]

Cad Saude Publica
Silva MBFCD, Silva CFD, Silva MJSD.
europepmc   +1 more source

[Impact of an integrated and centralized drug policy: the case of the province of Buenos Aires, ArgentinaImpacto de uma política de medicamentos integrada e centralizada: o caso da província de Buenos Aires, Argentina]. [PDF]

Rev Panam Salud Publica
Marín GH, Capallo AP, Cocco MH, Álvarez JI, Leone F, Pesci SA, Konfino J, Kreplak N.   +7 more
europepmc   +1 more source

Alteração de conservantes no pós-registro e possíveis impactos na qualidade dos medicamentos fabricados no Brasil

, 2014
Pós-graduação em Ciências Farmacêuticas ...
openaire   +1 more source

[MUR and MCA: allies to guarantee therapeutic success]. [PDF]

Farm Comunitarios
Díaz López C.
europepmc   +1 more source

[Effectiveness of GLP-1 receptor agonists in managing patients with type 2 diabetes]. [PDF]

Aten Primaria
Bejarano Romero F, Aragó Molés V, Morón Porrúa D, López Guerrero E, Suñer Barriga H, Canadell Vilarrasa L.   +5 more
europepmc   +1 more source

[Review of patients' medicine aid kits by community pharmacies in Alava]. [PDF]

Farm Comunitarios
Vinagre Sánchez C, Ibarra Barrueta M, Mosteiro M, Villacorta M, Sáenz de Santamaría M.   +4 more
europepmc   +1 more source